Finalize development of a sustainable programmatic structure to fulfill authorizing legislation.

Outcome
20% of portfolio full cost

FY 2004
Compendium of annual program products.

FY 2003
Finalize charters for the Steering Committee and Public-Private Partnerships.

Completed

SG-1/5
HP-14/17

Identify gaps in pharmaceutical effectiveness research and opportunities for implementation of evidence-based pharmaceutical usage.

Outcome
40% of portfolio full cost

FY 2005
Develop a mechanism to increase the number of CERTS.
Develop a dissemination plan with RICE.

FY 2004
Identify funding partners and expand personnel to include experts to manage projects.
Identify a plan for the economic component of CERTS and consolidation into a program note.

FY 2003
Identify funding partners—govt & non-govt.

Completed

SG-1/5
HP-14/17

Convene a multi-disciplinary group of experts to assist in identifying methods to determine how to measure under-use, its cost, and clinical consequences.

20% of portfolio full cost

FY 2003
Generate annual pharmaceutical update.

Completed

SG-1/5
HP-14/17

Develop knowledge and understanding of errors in health care by developing a patient safety research agenda specific to medications.

20% of portfolio full cost

FY 2005
Program staff will participate in or organize at least two relevant conferences.

FY 2004
Partner with CQUIPs and Patient Safety to focus an agenda on areas of overlap and gaps in medication error research.

FY 2003
Program staff will participate in or organize at least two relevant conferences.

Completed

SG-1/5
HP-14/17